
PPAR
Peroxisome Proliferator-Activated Receptors (PPARs) are a group of nuclear receptor proteins that function as transcription factors regulating the expression of genes involved in metabolism, particularly fatty acid storage and glucose metabolism. PPAR inhibitors are important tools for studying metabolic disorders such as diabetes, obesity, and cardiovascular diseases. These inhibitors can modulate lipid metabolism, insulin sensitivity, and inflammation, making them valuable in therapeutic research. At CymitQuimica, we offer a range of PPAR inhibitors to support your research in metabolic diseases, endocrinology, and drug development.
Products of "PPAR"
Sort by
THR-0921
CAS:THR-0921 (CLX-0921) is a peroxisome proliferator-activated receptor (PPAR) agonist that can be used to study cardiovascular and metabolic diseases.Formula:C28H25NO7SPurity:98.53%Color and Shape:SolidMolecular weight:519.57Furegrelate sodium
CAS:Furegrelate sodium (U-63557A) is an orally active thromboxane synthase inhibitor with an IC50 of 15 nM in platelets.Formula:C15H10NNaO3Purity:100%Color and Shape:SolidMolecular weight:275.23Ref: TM-T11339
5mg35.00€10mg52.00€25mg109.00€50mg202.00€100mg324.00€500mgTo inquire1mL*10mM (DMSO)37.00€K-111
CAS:K-111 is a PPAR alpha agonist. K-111 improves insulin resistance, reducing bodyweight, and ameliorating atherogenic dyslipidemia.Formula:C18H25Cl3O2Purity:99.88% - 99.93%Color and Shape:SolidMolecular weight:379.75